IRIS
RAVAGLIA, SABRINA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.559
AS - Asia 1.884
EU - Europa 1.795
SA - Sud America 226
AF - Africa 60
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.513
CN - Cina 888
SG - Singapore 432
IE - Irlanda 372
IT - Italia 307
DE - Germania 229
HK - Hong Kong 220
FI - Finlandia 201
RU - Federazione Russa 189
VN - Vietnam 181
UA - Ucraina 173
BR - Brasile 162
GB - Regno Unito 101
FR - Francia 81
IN - India 37
SE - Svezia 36
ZA - Sudafrica 31
BD - Bangladesh 25
CA - Canada 24
AR - Argentina 17
BE - Belgio 17
EC - Ecuador 17
JP - Giappone 16
NL - Olanda 16
PL - Polonia 14
ES - Italia 13
MX - Messico 13
IQ - Iraq 10
MA - Marocco 10
PK - Pakistan 10
CL - Cile 7
CO - Colombia 7
AT - Austria 6
ID - Indonesia 6
LT - Lituania 6
MY - Malesia 6
AU - Australia 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
KR - Corea 5
TN - Tunisia 5
TR - Turchia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
ET - Etiopia 4
GR - Grecia 4
JO - Giordania 4
PE - Perù 4
SA - Arabia Saudita 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
PH - Filippine 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
EG - Egitto 2
KW - Kuwait 2
NP - Nepal 2
OM - Oman 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 6.533
Salva come PNG Salva come JPEG
Città #
Chandler 376
Dublin 369
Singapore 257
San Jose 255
Ashburn 242
Dallas 224
Hong Kong 213
Jacksonville 206
Beijing 187
Nanjing 164
Boardman 121
Helsinki 79
Munich 73
Los Angeles 71
Milan 68
Ho Chi Minh City 67
Nanchang 60
Lauterbourg 53
Ann Arbor 52
Jiaxing 52
Pavia 52
Changsha 51
Lawrence 50
Princeton 50
Medford 49
Hebei 48
New York 48
Hanoi 44
Shenyang 41
Wilmington 41
Shanghai 35
Buffalo 34
Hangzhou 33
Turku 30
Johannesburg 28
Moscow 28
Tianjin 21
Council Bluffs 20
Frankfurt am Main 19
London 18
Brussels 17
São Paulo 17
Redondo Beach 16
Tokyo 16
Orem 14
Trieste 14
Verona 14
Toronto 13
Warsaw 13
Bergamo 12
Turin 11
Amsterdam 10
Brooklyn 10
Da Nang 10
Seattle 10
The Dalles 10
Woodbridge 10
Atlanta 9
Denver 9
Manchester 9
Rome 9
San Francisco 9
Chicago 8
Houston 8
Cagliari 7
Chennai 7
Dhaka 7
Falkenstein 7
Montreal 7
Nuremberg 7
Piscataway 7
Poplar 7
Pune 7
Santa Clara 7
Stockholm 7
Biên Hòa 6
Charlotte 6
Florence 6
Gorlago 6
Kunming 6
Lahore 6
Lodi 6
Mexico City 6
Modena 6
Naples 6
Norwalk 6
Belo Horizonte 5
Bologna 5
Boston 5
Brno 5
Columbus 5
Fairfield 5
Haiphong 5
Monza 5
Quito 5
Travaco Siccomario 5
Zhengzhou 5
Addis Ababa 4
Athens 4
Baghdad 4
Totale 4.417
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 302
A first update on mapping the human genetic architecture of COVID-19 192
A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy. 160
Changes in nutritional status and body composition during enzyme replacementtherapy in adult-onset type II glycogenosis. 142
Dietary treatment in adult-onset type II glycogenosis. 137
Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant. 135
Enzyme replacement therapy (ERT) in adult-onset type II glycogenosis (GSDII) 134
Cognitive impairment and central motor conduction time in chronic alcoholics. 127
Severe recurrent myelitis in patients with hepatitis C virus infection 118
Clinical MRI dissociation in myelopathy: a clue to sarcoidosis? 118
Aspetti clinici e patogenetici della comorbidita’ emicranica. 118
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 117
Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up 117
Recombinant alpha-glucosidase in adult-onset type II glycogenosis: The experience with the first Italian patient, from expanded access programmes to marketing authorization 117
Guillain-Barré syndrome associated with SARS-CoV-2 117
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 116
Early-onset ptosis in type II glycogenosis 115
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patientswith Alzheimer's disease and vascular dementia. 114
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 113
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD) 112
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 111
The angiotensin-converting enzyme insertion/deletion polymorphysm modifies the clinical outcome in patients with Pompe disease. 110
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 110
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 109
Genotype-phenotype correlation in Pompe disease, a step forward. 109
NMO-IgG-negative relapsing myelitis 108
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encphalomyelitis. 108
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 105
Severe recurrent myelitis in patients with hepatitis C virus infection patients 104
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 104
Combined central and peripheral demyelination: comparison of adult and pediatric series 103
Strabismo parossistico: Meccanismi corticali e meccanismi periferici nella fisiopatologia di due casi con analoga fenomenologia critica 103
Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset Type II Glycogenosis? 101
Enzyme replacement therapy in severe adult-onset glycogen storage disease type II 101
Emicrania emiplegica familiare: dalla genetica alla clinica. 100
Triggering migraine attacks:the role of nitroderivatives. 100
Recombinant alglucosidase alpha (rhGAA) in adult-onset type II glycogenosis (GSDII): A follow-up study before and after treatment 98
Efficacy of propafenone in paramyotonia congenita 97
Outcome after Two Years of Enzyme Replacement Therapy (ERT) in 29 Patients with Late-Onset Type II Glycogenosis (GSDII) 97
Pathogenetic role of myelitis for syringomyelia. 96
Enzyme replacement therapy in adult-onset type II glycogenosis 91
RECOMBINANT ALGLUCOSIDASE ALFA IN ADULT-ONSET GLYCOGENOSIS TYPE II: A FOLLOW-UP STUDY BEFORE AND AFTER TREATMENT 90
Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease. 89
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 88
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 88
Presyrinx in children with Chiari malformations 86
Retinal migraine as unusual feature of cerebral autosomal dominantarteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL) 80
Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients 80
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 80
Ocular neuromyotonia with both tonic and paroxysmal components due to vascular compression 79
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 75
Enzyme replacement therapy in late-onset type II glycogenosis. 75
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. 73
Erectile dysfunction as a sentinel symptom ofcardiovascular autonomic neuropathy in heavy drinkers 71
The diagnosis of migraine: clinical and instrumental aspects 71
Post-infectious and postvaccinal acute disseminated encephalomyelitis occurring in the same patients 70
Severe steroid-resistant post-infectious encephalomyelitis: General features and effects of IVIg 69
Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2 69
ENZYME REPLACEMENT THERAPY IN LATE-ONSET PHENOTYPES OF GLYCOGENOSIS TYPE 2: RESULTS OF AN ITALIAN MULTICENTER STUDY 68
Post-infectious inflammatory disordes:sub-groups based on prospective follow-up. 66
Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful? 58
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 57
Enzyme replacement therapy with Alglucosidase alfa in juvenile-adult glycogenosis type 2 patients 54
null 34
Guillain‐Barré syndrome and COVID‐19: A 1‐year observational multicenter study 33
Quantitative MRI Biomarkers for Early Muscle Involvement in Late Onset Pompe Disease 8
Dynamic MR of Muscle Contraction During Electrical Muscle Stimulation: Potential Application to the Evaluation of Neuromuscular Diseases 4
Totale 6.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022221 5 3 4 3 0 4 3 11 11 2 36 139
2022/20231.202 84 90 12 174 97 123 2 61 438 13 96 12
2023/2024398 49 73 11 18 28 102 5 26 5 10 19 52
2024/20251.113 34 96 60 31 35 74 68 51 248 42 105 269
2025/20262.328 209 203 260 220 286 109 452 91 232 137 81 48
Totale 6.601